Zobrazeno 1 - 2
of 2
pro vyhledávání: '"James H. Tabibian, M.D."'
Association between serum IgE level and adverse clinical endpoints in primary sclerosing cholangitis
Autor:
James H. Tabibian, M.D., Felicity Enders, Mohamad H. Imam, Gururaj Kolar, Keith D. Lindor, Jayant A. Talwalkar
Publikováno v:
Annals of Hepatology, Vol 13, Iss 3, Pp 384-389 (2014)
Introduction. Primary sclerosing cholangitis (PSC) is an idiopathic hepatobiliary disorder associated with an increased risk for cholangiocarcinoma (CCA) and a median survival time of 12 years. Reliable predictors of CCA and other major adverse event
Externí odkaz:
https://doaj.org/article/6142ff952a1841deae54813240827925
Autor:
James H. Tabibian, M.D., Mohit Girotra, Hsin-Chieh Yeh, Dorry L. Segev, Murat T. Gulsen, Guldane Cengiz-Seval, Vikesh K. Singh, Andrew M. Cameron, Ahmet Gurakar
Publikováno v:
Annals of Hepatology, Vol 12, Iss 4, Pp 395-401 (2013)
Introduction. Sirolimus has inhibitory effects on epithelial healing and cholangiocyte regeneration. In liver transplantation (LT) patients, these effects may be greatest at the biliary anastomosis. We therefore investigated whether sirolimus use is
Externí odkaz:
https://doaj.org/article/5e446e46a7d243859921d08561f8b87f